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longitudinals-lacking (lola) was identified in Drosophila as a gene encoding several alternatively spliced transcription factors involved in axon
guidance. Here we report that lola also plays a critical role in programmed cell death in the ovary. lola mutant germline clones show a high
percentage of egg chambers with nurse cell nuclei persisting past stage 13, indicating a block in developmental nurse cell death. Mutants also
show a disruption in the induced programmed cell death that occurs during mid-oogenesis in response to starvation. Further characterization
revealed that lola germline clones exhibit abnormal nuclear organization which becomes increasingly severe with age. Chromatin appears diffuse
and fails to condense properly or undergo DNA fragmentation in dying nurse cells. Masses of nuclear material accumulate in the ovaries of older
flies containing lola germline clones. We propose that lola is necessary for complete chromatin condensation which occurs during programmed
cell death in the ovary. Alleles differed in the strength of their phenotypes but interestingly, the severity of their ovarian phenotypes was
independent of the strength of their neuronal phenotypes, suggesting a differential requirement for individual lola isoforms in the ovary and
nervous system.
© 2007 Elsevier Inc. All rights reserved.Keywords: Programmed cell death; Apoptosis; Oogenesis; Drosophila; lola; Germline clones; Chromatin condensation; Nurse cellsIntroduction
In Drosophila, the process of oogenesis is divided into 14
stages based on well defined morphological characteristics
(King, 1970; Spradling, 1993). A Drosophila ovary consists of
15–20 ovarioles, each containing several egg chambers at
different stages of development. Each egg chamber is
surrounded by somatically derived follicle cells and contains
15 germline-derived nurse cells in addition to the oocyte. The
nurse cells serve to provide the developing oocyte with essential
proteins, organelles, and other cellular components.
Programmed cell death (PCD) is known to occur during early,
mid-stage, and late-stage Drosophila oogenesis (reviewed in
McCall, 2004). In response to nutrient deprivation, germline cyst
cells may undergo PCD in the beginning of oogenesis in the⁎ Corresponding author. Fax: +617 353 8484.
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doi:10.1016/j.ydbio.2007.01.029germarium, or entire egg chambers may die around stage seven
or eight, indicating that there are checkpoints at specific stages of
oogenesis. During lateDrosophila oogenesis, as a part of normal
egg chamber development, the nurse cells undergo PCD
resulting in a mature oocyte surrounded by the follicle cells
that make the eggshell. Cytoskeletal changes occur as nurse cell
PCD initiates, allowing for the transfer of cytoplasm from the
nurse cells through intracellular bridges into the oocyte, a pro-
cess commonly referred to as “dumping”. After the nurse cells
transfer their mRNA, organelles, and proteins into the develop-
ing oocyte, the remaining nurse cell nuclei undergo chromatin
condensation and DNA fragmentation (Cavaliere et al., 1998;
Foley and Cooley, 1998; McCall and Steller, 1998). Eventually
the nurse cell remnants are engulfed by the neighboring follicle
cells (Cummings and King, 1970; Nezis et al., 2000).
Although these are well established characteristics of PCD in
the ovary, it is currently unclear what role nurse cell DNA
fragmentation plays, along with chromatin condensation, in the
PCD process. Drosophila mutants lacking caspase-activated
DNase (CAD) failed to undergo nucleosomal DNA fragmenta-
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DNA, and the nurse cells appeared to complete PCD (Mukae et
al., 2002). Upon induction of apoptosis, lack of DNA
fragmentation was also observed in human cell lines expressing
a caspase-resistant form of CAD inhibitor (ICAD), which is
normally cleaved by caspases to release CAD (McIlroy et al.,
1999). However, nucleosomal DNA fragmentation was still
present in mice expressing a caspase-resistant ICAD (McIlroy et
al., 2000). Flies containing a mutation in the lysosomal acid
DNase gene, dDNaseII, exhibited enhanced DNA fragmentation
along with an accumulation of nurse cell DNA in the ovary. In
addition, flies lacking CAD and DNaseII also showed DNA
accumulation (Mukae et al., 2002). These results suggest that
CAD and DNaseII may be involved in a two-step process
mediating DNA fragmentation in the ovary (Mukae et al., 2002)
similar to the three-step process proposed for C. elegans (Wu et
al., 2000).
Previous studies have shown that many of the genes known
to play essential roles in PCD duringDrosophila embryogenesis
and organogenesis are not necessary for PCD during oogenesis
(Foley and Cooley, 1998; reviewed in Baum et al., 2005). This
suggests that a different set of genes may be controlling this
process in the ovary. Furthermore, the checkpoint PCD pathway
active in mid-oogenesis appears to require different genes than
the developmental PCD pathway active in later stages (reviewed
in McCall, 2004). Over-expression of the inhibitor of apoptosis
protein, Diap-1, has been shown to significantly block the mid-
stage checkpoint cell death pathway, but has a milder effect on
late-stage nurse cell death (Peterson et al., 2003; Mazzalupo and
Cooley, 2006; J. Baum and KM, unpublished). Also, mutations
in the effector caspase gene dcp-1 prevent starvation-induced
PCD but not late-stage developmental PCD (Laundrie et al.,
2003). In fact, relatively few genes involved in late-stage
developmental PCD have been identified thus far.
To identify genes necessary for proper nurse cell develop-
mental PCD, we performed a germline clone (GLC) screen of
chromosome 2R. One of the genes identified through this screen
was longitudinals-lacking (lola). Lola was previously identified
as a transcription factor involved in axon guidance (Giniger et
al., 1994; Madden et al., 1999; Crowner et al., 2002; Goeke et
al., 2003). Specifically, Lola has been shown to regulate the
expression of axon guidance proteins Robo and Slit (Crowner et
al., 2002). Furthermore, Lola has been shown to interact with
chromosomal kinase JIL-1 (Zhang et al., 2003b), suggesting
that it is also involved in chromatin structure modification and
its roles in development could be more broad than initially
thought. The lola gene spans over 61 kb, contains 32
alternatively spliced exons, and is known to encode at least
20 different isoforms (Goeke et al., 2003; Ohsako et al., 2003).
Transcripts for all 20 isoforms contain common exons 5–8,
which encode a BTB (Bric-a-brac, Tramtrack, Broad complex)
domain involved in dimerization. lola additionally contains
four alternatively spliced 5′ exons and 24 alternatively spliced
3′ exons. The 3′ variable exons encode several unique zinc
finger motifs present in 17 of the 20 isoforms (Goeke et al.,
2003; Horiuchi et al., 2003; Ohsako et al., 2003). lola has been
shown to exhibit intragenic complementation through inter-allelic trans-splicing events, indicating that this is a very large
and complex locus (Horiuchi et al., 2003).
Here we show that lola is also required for proper PCD in the
ovary. Through GLC analysis, we have determined that loss of
lola results in a block in the developmental PCD which occurs
late in oogenesis. Interestingly, lola mutants also show a delay
in checkpoint PCD which occurs during the mid-stages,
suggesting lola affects events common to both forms of PCD.
Specifically we have observed a disruption in normal nurse cell
nuclear organization, chromatin condensation, and DNA
fragmentation that normally occur during PCD. We also show
a differential requirement for individual lola splice forms in the
ovary and in embryonic development of the nervous system. We
hypothesize that Lola isoform K is specifically required for
nuclear organization, chromatin condensation, and DNA
fragmentation in the ovary during PCD.
Materials and methods
Drosophila strains
All fly lines were obtained from the Bloomington Stock Center unless
otherwise noted. Seven deficiency lines and 35 lethal alleles were used for
complementation analysis including btbk09901 and lola00642. lola5D2, lola4E4
(Giniger et al., 1994), lolaORC4, lolaORE50 (Goeke et al., 2003), and lolaORE120
(Crowner et al., 2002) were gifts from Ed Giniger. The BB127 enhancer trap line
(Schüpbach and Wieschaus, 1991) was a gift from Trudi Schüpbach. yw67c23
flies served as a wild-type control. Nutrient deprivation experiments were
carried out as described (Peterson et al., 2003). All crosses were carried out at
25 °C on standard fly food unless otherwise noted.
Genetic manipulations
The screen from which lola629 was isolated was carried out in the following
manner. Males from two different isogenic dp FRTG13/CyO recombinant fly
lines were subjected to 35 mM EMS in 10% sucrose overnight. These males
were then crossed to y2 ras v RpII215shits/FM7, l; Gla/CyO virgin females,
resulting in only female progeny. In the F1 generation, single non-Gla females
were crossed with y w hsflp BB127; FRTG13 ovoD/CyO males containing a
heat-shock inducible flippase, the BB127 enhancer trap encoding nuclear β-
galactosidase, and FRTG13 marked with the dominant female sterile mutation
ovoD. On days 5 and 6 or as soon as third instar larvae were visible, progeny
were heat shocked in a 37° water bath for 1 h. y w hsflp BB127/FM7, l or +; dp
FRTG13/FRTG13 ovoD females were collected from the F2 generation and
conditioned on wet yeast paste along with males. These potential GLC
containing females were dissected after being conditioned 3–10 days. Siblings
were used to make balanced stocks of each screen line that exhibited an
oogenesis phenotype as determined through DAPI staining.
To generate GLCs of existing lola alleles, the FRT site from FRTG13 L/CyO
flies was recombined onto lola stocks. Correct stocks were determined through
eye color, loss of L, and failure to complement the original lola stock and other
alleles.
Staining procedures
For antibody and DAPI staining, females were conditioned on wet yeast
paste and ovaries were dissected, fixed, and stained as described (Verheyen and
Cooley, 1994) except they were mounted in Vectashield with DAPI (Vector
Labs, Burlingame, CA). For propidium iodide staining following the Cleaved
Caspase-3 antibody staining procedure, fixed tissue was incubated with
600 μg/ml RNase in PBS for 2 h and stained with 1 μg/ml propidium iodide
(Molecular Probes, Eugene, OR) in PBS for 30 min in the dark, washed
2×15 min in PBS, and mounted in Vectashield (Vector Labs, Burlingame, CA).
Cleaved Caspase-3 antibody (Cell Signaling Technology, Danvers, MA) was
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ImmunoResearch Labs, West Grove, PA) was used at a 1:200 dilution. Lamin
Dm0 antibodies ADL101 and ADL84.12 (developed by Paul A. Fisher and
obtained from Developmental Studies Hybridoma Bank, Iowa City, Iowa) were
used at a 1:1 dilution. Secondary antibody goat-anti-mouse-Cy3 (Jackson
ImmunoResearch Labs, West Grove, PA) and secondary antibody goat-anti-
mouse Alexa Fluor 488 (Molecular Probes, Eugene, OR) were used at a 1:200
dilution. For rhodamine–phalloidin staining, tissue was fixed as described
(Verheyen and Cooley, 1994), then rinsed with Drosophila Ringer's solution
2×10 min. Samples were then incubated in the dark for 20 min with 50–100 μl
rhodamine–phalloidin (Molecular Probes, Eugene, OR) made by diluting a
10 μl aliquot with 100 μl Ringer's. Rhodamine–phalloidin was removed and
samples were rinsed 2×1 min with PBS and mounted in Vectashield with DAPI
(Vector Labs, Burlingame, CA). Alternatively, for double staining with Lamin
Dm0 ADL84.12 and rhodamine–phalloidin, tissue was rinsed 2×10 min in
Drosophila Ringer's solution following the Lamin Dm0 antibody staining
procedure. Tissues were then incubated with rhodamine–phalloidin as described
above. The embryonic CNS was visualized with the BP102 antibody (developed
by C. Goodman and obtained from Developmental Studies Hybridoma Bank,
Iowa City, Iowa), used at a 1:3 dilution. For BP102 antibody staining, embryos
from heterozygous adult flies were collected on egg plates overnight, fixed, and
stained as described (Patel, 1994). X-gal staining was carried out as described
(McCall and Steller, 1998). TUNEL analysis was carried out as described
(McCall and Peterson, 2004). Images were taken using an Olympus MagnaFire
SP digital camera for samples viewed on an Olympus BX60 microscope, while
confocal images were taken on an Olympus Fluoview confocal microscope.
Western blotting
Extracts of total embryonic or ovarian protein were prepared using 40 14–
17 h old embryos or 4 pairs of ovaries for each genotype and separated by SDS-Fig. 1. lola alleles vary in the severity of their GLC phenotypes. All egg chambers hav
remaining nurse cell nuclei. (B–H) Representative stage 14 egg chambers containin
defects during oogenesis including dumpless egg chambers. However, lola4E4 (C) loPAGE. Western analysis was performed by standard methods using anti-Lola
antibody (Giniger et al., 1994) at a 1:350 dilution and visualized by enhanced
chemiluminescence (ECL). Lamin Dm0 antibody ADL101 (developed by Paul
A. Fisher and obtained from Developmental Studies Hybridoma Bank, Iowa
City, Iowa) was used as a loading control at a 1:50 dilution.
DNA sequencing
lola629 flies were balanced over CyO, Kr-GAL4 UAS-GFP. DNA was
obtained from 14 to 17 h old non-GFP embryos and amplified through PCR.
Primer pairs used for amplification of lola exons 21 and 22 were 5′
GAACTAAAACGAAAACGGAACC3′ and 5′GATGGGGATGTAT-
GATTGTCG3′, 5′TCATCGGAATGCGGTAAGTC3′ and 5′TGATG-
GACCGTTTGCAGTTC3′, 5′CCATCCAGCATCAACATCAC3′ and 5′
CTCACAATCCTCCCAACTTTC3′. PCR products were purified using QIA-
quick PCR purification kit (Qiagen, Valencia, CA) and sent to MWG-Biotech,
Inc. (High Point, NC) for DNA sequencing. The background strain used for the
screen was sequenced in a similar manner.Results
Screen line 629 displays dumpless egg chambers, persisting
nurse cell nuclei, and too many nurse cells
To identify genes involved in PCD in the Drosophila ovary, a
genetic screen was undertaken in which GLCs were made of
chromosome 2R after EMS mutagenesis (see Materials and
methods). This homozygousmutant ovary tissuewas then stainede been DAPI-stained. (A) Control, yw stage 14 egg chambers do not contain any
g GLCs of the indicated lola alleles show that most cause moderate to severe
oks wild-type.
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egg chambers with altered numbers of nurse cells, excessive
degeneration, or nurse cells surviving past stage 13 of oogenesis.
Screen line 629 exhibited a variety of interesting oogenesis
defects, with 90% of the stage 14 egg chambers appearing
abnormal. The major phenotypes observed were dumpless egg
chambers or egg chambers with persisting nurse cell nuclei.
Dumpless refers to stage 14 egg chambers in which the nurse
cells have failed to transfer their cytoplasmic contents into the
oocyte. In these egg chambers, the nurse cell nuclei are still
intact and do not appear to be undergoing PCD (Fig. 1B).
Persisting nurse cell nuclei refers to stage 14 egg chambers in
which the nurse cells have transferred their cytoplasmic
contents to the oocyte, but their nuclei have subsequently failed
to undergo PCD including nuclear condensation, DNA
fragmentation, and/or engulfment. The only difference in
appearance between these two categories of egg chambers is
the presence or absence of cytoplasm. Additionally, some egg
chambers were “cup-shaped,” mature egg chambers in which
the chorion failed to extend around and seal the anterior end of
the oocyte resulting in an open-ended chorion phenotype
(Schüpbach and Wieschaus, 1991). These cup-shaped egg
chambers also appear to have dorsal appendage material which
has not elongated properly. In addition to these three major
phenotypes, some early and mid-stage egg chambers in screen
line 629 contain more than 15 nurse cells, a phenotype that
could be due to altered PCD in the germarium (Smith et al.,
2002), fusion of egg chambers, or too many cell divisions. TheFig. 2. Intragenic complementation analysis. (A) Complementation results with differ
lola629. Offspring from the F1 generation of the indicated cross were counted. Per
expected number of straight winged flies). Expected number of straight winged flies=
of P-element insertions in lola4E4, lola00642, and lola5D2, and EMS-induced mutatio
drawing is not to scale (Horiuchi et al., 2003).mutant GLCs also showed an excessive amount of degeneration
in mid-oogenesis.
Line 629 contains a lethal mutation mapping to the lola locus
Complementation analysis was performed with deficiencies
spanning chromosome 2R, and line 629 was found to fail to
complement Df(2R)stan1. After testing complementation with
five smaller deletions mapping to the same region, we tested line
629 for complementation with several lethal alleles mapping to
the appropriate region of 2R. Line 629 failed to complement two
mutations including lola00642, and a P-element insertion line
known as btbk09901 (bumper-to-bumper). Although btbk09901
had been found to complement other alleles of lola (Prokopenko
et al., 2000), our data indicate that btbk09901 is an allele of lola.
btbk09901 shows nervous system defects (Kania et al., 1995)
similar to alleles of lola (Giniger et al., 1994; Madden et al.,
1999; Crowner et al., 2002; Goeke et al., 2003; Horiuchi et al.,
2003), and we have found that btbk09901 fails to complement
several alleles of lola including lola00642, lola5D2, lolaORC4,
lolaORE50, lola4E4, and lolaORE120 (data not shown). Based on
these results, we conclude that 629 is an allele of lola.
lola is a large gene with 32 exons spanning over 61 kb,
making it difficult to pinpoint the precise location of the
mutation in line 629 (hereafter referred to as lola629). However,
lola alleles are known to exhibit intragenic complementation
through trans-splicing (Horiuchi et al., 2003), so we used this
phenomenon to our advantage when mapping the mutation inent lethal alleles of lola helped narrow down the location of the lethal mutation in
cent viability is calculated as 100× (observed number of straight winged flies/
1/2(observed number of curly winged flies) (Horiuchi et al., 2003). (B) Locations
ns in lolaORE120, lolaORC4, and lolaORE50. Only relevant exons are depicted and
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chromosome are spliced together with exons transcribed from
the homologous chromosome to make a complete mRNA. As a
result, mutations in different exons can complement one another
because normal mRNA can still be made. Complementation
analysis was performed using five additional lola alleles, several
of which have demonstrated intragenic complementation
(Horiuchi et al., 2003). Fig. 2A shows the results of this study.
lola629 failed to complement all lola alleles that were tested with
the exception of lola4E4 and lolaORE120. lola4E4, a P-element
allele containing an insertion upstream of 5′ variable exon 3
(Giniger et al., 1994; Fig. 2B), is described as a strong allele
(Giniger et al., 1994) and we found that it failed to complement
other alleles in our study including lola5D2 and lola00642.
lolaORE120 is a weaker EMS allele mapping to the constant region
which includes exons 5–8 (Crowner et al., 2002; Fig. 2B).
Importantly, lola629 failed to complement both lolaORC4 and
lolaORE50 which harbor mutations mapping to the 3′ variable
exon 22 included in isoform K (known as lola-PI, FlyBase)
(Goeke et al., 2003). Horiuchi et al. (2003) previously
determined that alleles with mutations mapping to the 3′
variable regions are likely to complement alleles with mutations
mapping to 3′ variable exons corresponding to different
isoforms. Furthermore, it was determined that mutations
mapping to the 3′ variable region are likely to complement
mutations mapping to the constant region of lola including
lolaORE120 because of trans-splicing (Horiuchi et al., 2003).
Because lola629 showed the same complementation pattern as
lolaORC4 and lolaORE50, we predicted that the mutation in
lola629 would also map to the 3′ variable region encoding
isoform K which includes exons 21 and 22. Interestingly,
lolaORC4 and lolaORE50 are known to have far more subtle
neuronal defects than other alleles, and in particular, they lack
the severe CNS phenotype that lola is named for (Goeke et al.,
2003). lola629 was also found to lack this neuronal phenotype
(Table 1), providing further support for our hypothesis that the
lola mutation was in exons encoding isoform K.Table 1
Comparison of ovarian and neuronal phenotypes in lola alleles
Genotype Relative phenotypic severity
Ovarian a Neuronal
lola629 +++ − (this study, data not shown) b
lola4E4 − +++ (Giniger et al., 1994)
lolaORE120 +++ + (Crowner et al., 2002)
lola5D2 ++ +++ (Giniger et al., 1994)
lola00642 +++ +++ (this study, data not shown)
lolaORC4 +++ +/− (Goeke et al., 2003)
lolaORE50 NDc +/− (Goeke et al., 2003)
btbk09901 + ++ (Kania et al., 1995)
FRTG13 d − ND
+++ indicates a strong mutant phenotype, ++ and + indicate moderate
phenotypes, +/− indicates a weak phenotype, and − indicates no abnormal
phenotype.
a All ovarian phenotypes are based on GLC analysis.
b This result is based on the presence of longitudinal axons in homozygous
mutant embryos. Other possible neuronal phenotypes have not been examined.
c Not determined.
d Examined for an ovarian phenotype as a control.Upon sequencing exons 21 and 22 using DNA from lola629
homozygous embryos, a C to T mutation in exon 22 was found
which was not present in the original strain used for the EMS
mutagenesis screen. This mutation resulted in a glutamine being
replaced with a stop codon at residue 635 of the K isoform of
Lola. This isoform contains two zinc finger domains near the C-
terminus (Goeke et al., 2003; Ohsako et al., 2003), and the early
stop codon would terminate the protein over 250 residues
upstream of these zinc finger domains, most likely disrupting
the function of this protein. The finding that lola629 contains an
isoform-specific mutation suggests that isoform K plays an
important role during PCD in the ovary.
lola alleles differ in the severity of their ovarian phenotype
Because lolaORC4, lolaORE50, and lola629 each exhibit a
weak neuronal phenotype (Table 1), and lola629 shows a very
strong ovarian phenotype (Fig. 1B, Table 1), we wished to
determine if other isoform K alleles show this strong ovarian
phenotype as well. We also wanted to see if there was a
relationship between the severity of neuronal phenotypes and
severity of ovarian phenotypes among the lola alleles which
would indicate isoform-specific requirements in these two areas
of development. Therefore, GLCs were made from six lola
alleles in addition to lola629. Fig. 1 includes representative
pictures of stage 14 egg chambers containing GLCs of these
alleles along with a wild-type stage 14 egg chamber for
comparison (Fig. 1A). The results indicate that most lola alleles
do cause dumpless egg chambers and/or persisting nurse cell
nuclei (Figs. 1B and D–H). However, although lola4E4 shows
severe neuronal phenotypes (Giniger et al., 1994), and our
recombinant FRT lola4E4 line retained a strong CNS phenotype
(data not shown), surprisingly we did not detect a significant
phenotype in the ovary (Fig. 1C). Fig. 3 shows a quantitative
analysis of the major phenotypes observed in these GLCs in
comparison with wild-type GLCs (Fig. 3, FRTG13). Interest-
ingly, the isoform K-specific mutants lola629 and lolaORC4 have
the strongest ovarian phenotype (Fig. 3). lolaORE120 is thought
to be a weak allele and shows only a mild neuronal phenotype
(Crowner et al., 2002). However, lolaORE120 GLCs also
exhibited a significant ovary phenotype (Fig. 3, Table 1).
Strong alleles thought to disrupt function of all Lola isoforms,
with the exception of lola4E4, show both the severe neuronal
and ovarian phenotypes. These alleles include lola5D2 and
lola00642 (Fig. 3, Table 1). btbk09901 also exhibits a neuronal
phenotype and was found to have a significant oogenesis
phenotype (Fig. 3, Table 1). Taken together, these results
suggest that isoform K is critical for oogenesis, but not for axon
guidance during embryogenesis.
Lola isoform K is normally expressed during oogenesis and is
missing in lolaORC4, lola629, and lolaORE50 mutants but not in
lola4E4 mutants
To shed light on why isoform K-specific alleles of lola
exhibited strong ovarian phenotypes while lola4E4 mutant
ovaries appeared wild-type, western analysis was done using
Fig. 3. Quantification of ovarian phenotypes of different lola alleles in order of increasing severity. Stage 14 egg chambers were classified as one of four indicated
categories. Those classified as other had dorsal appendage defects or were cup-shaped but did not contain persisting nurse cell nuclei and were not dumpless. FRTG13
germline clones were analyzed as a control. n=the total number of stage 14 germline clone egg chambers classified.
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been determined that lolaORC4 mutants express a truncated
version of isoform K (Goeke et al., 2003). We wanted to see if
this was also the case with lola629 mutants because these two
alleles have very similar phenotypes. Using an antibody that
recognizes a portion of Lola encoded by the common region
(Giniger et al., 1994), we observed that lola629 and lolaORC4
homozygous embryos are each missing a large Lola isoform
when compared with yw embryos. In addition, we observed a
similar phenomenon in lolaORE50 embryos (Fig. 4A, arrowhead).
This is consistent with each allele disrupting the expression of
isoform K. It was also observed that like lolaORC4, lola629
mutants express a truncated version of this isoform seen as the
appearance of a unique smaller band. Interestingly, these
truncated proteins are expressed at a higher level than other
Lola isoforms. The third isoform K-specific allele, lolaORE50,
also expressed a truncated version of isoform K, although it wasFig. 4. Lola isoform K expression is necessary for normal oogenesis. (A) Extracts fro
subjected to western analysis using an antibody that recognizes the constant region of
the right. Compared with yw control embryos, those heterozygous and homozygous f
of isoform K (arrows). lola629, lolaORC4, lolaORE50, and lola5D2 homozygotes lac
(arrowhead). (B) The same membrane used for panel Awas probed with an antibody
lane. (C) Protein extracts from ovaries of the genotypes indicated above were subjecte
containing GLCs of lola629 express a truncated version of isoform K (arrow), whilenot as highly expressed as those seen in lola629 and lolaORC4
embryos (Fig. 4A, arrows). These results suggest that lolaORC4
and lola629 have a strong ovarian phenotype due specifically to
the lack of expression of isoform K.
lola4E4 GLCs displayed no significant ovarian phenotype
although lola4E4 has been previously considered a strong allele
(Giniger et al., 1994). To determine if the lack of an ovarian
phenotype was due to the retention of functional protein in
lola4E4 mutants, protein from homozygous embryos was used in
western analysis. It was determined that lola4E4 mutants still
express many Lola isoforms, including isoform K, albeit at
lower levels than in yw control embryos (Fig. 4A). In contrast,
lola5D2, another strong lola allele (Giniger et al., 1994), had a
strong ovarian phenotype. This allele also showed faint
expression of some lola isoforms, however, importantly, there
was little, if any, expression of isoform K (Fig. 4A). The
presence of Lola isoform K in lola4E4, which unexpectedly didm embryos of the genotypes indicated above were separated by SDS-PAGE and
Lola. The positions of standard protein molecular weight markers are indicated to
or lola629, as well as lolaORC4, and lolaORE50 embryos express truncated versions
k expression of the normal sized isoform K while lola4E4 retains expression
for Lamin Dm0 to verify that comparable amounts of protein were added to each
d to western analysis as in panel A. Ovaries from lola629 heterozygotes and those
only the GLCs lack expression of the normal sized isoform (arrowhead).
777B. Paige Bass et al. / Developmental Biology 304 (2007) 771–785not show strong ovarian phenotypes, is further evidence that
this isoform, in particular, is important during oogenesis.
To determine exactly which isoforms of Lola are expressed
during oogenesis, western analysis was done again using the
antibody against the common region of Lola that recognizes all
isoforms (Giniger et al., 1994). Total protein extracts from yw
and lola629 heterozygous ovaries as controls and ovaries
containing GLCs of lola629 were probed (Fig. 4C). The results
show that several isoforms are present in ovaries of control flies
including isoform K. However, as was seen in homozygous
embryos, this isoform is missing in lola629 GLCs (Fig. 4C,
arrowhead) and a truncated version is apparent in both the
GLCs and the heterozygous ovary extracts (Fig. 4C, arrow).
Mutations in lola block DNA fragmentation during mid-stage
checkpoint and late-stage developmental programmed
cell death
To determine specifically if the ovarian phenotypes observed
in lola mutants were due to an absence, delay, or disruption of
PCD, TUNEL (Terminal deoxynucleotidyl Transferase Biotin-
dUTP Nick End Labeling) analysis was performed on GLCs.
TUNEL analysis detects fragmented DNA, one of the hallmarks
of PCD. For this, and all subsequent phenotypic analysis in the
ovary, both lola629 and lolaORC4 GLCs were examined, due to
the similar degree of abnormality and molecular nature of the
alleles. When tested in parallel, no significant differences
between the two alleles were observed. In addition, both
heterozygous siblings of each allele and yw flies were used as
“wild-type” controls (as noted in figures). No significant
differences were observed between these controls.Fig. 5. lola GLCs do not undergo DNA fragmentation during checkpoint or devel
performed on all egg chambers. (A) Heterozygous mid-stage egg chambers from nutr
cell nuclei. (B) As an internal control, ovoD tissue, surrounding lolaORC4GLCs, did co
containing lolaORC4 GLCs are not TUNEL positive. Arrows indicate three separate e
chambers display TUNEL positive nurse cells during developmental PCD. (F) lolaOTo determine if lola played a role in the checkpoint cell death
that occurs during mid-oogenesis, flies were starved by feeding
them a 10% sucrose solution, and dying mid-stage egg
chambers were analyzed by TUNEL and DAPI staining. The
presence of DNA fragmentation, as depicted by dark-purple
staining, was seen in the nurse cells of controls (Fig. 5A). Many
degenerating mid-stage egg chambers were seen in lola mutant
GLCs, even under well-fed conditions. However, although
TUNEL-positive cells were seen in the surrounding ovoD tissue
(Fig. 5B, arrows), most degenerating mid-stage lolaORC4 GLCs
were not TUNEL-positive (Fig. 5C, arrows point to three
individual degenerating egg chambers) indicating a block in
DNA fragmentation during checkpoint PCD.
During normal development, nurse cells become TUNEL-
positive between late-stage 12 and early stage 13, indicating
the presence of fragmented DNA (Foley and Cooley, 1998;
Figs. 5D and E). However, most dumpless egg chambers from
lolaORC4 GLCs did not contain any TUNEL-positive nurse
cells (Fig. 5F) indicating the absence of DNA fragmentation
and incomplete developmental PCD. The same phenotypes
were observed in lola629 GLCs (data not shown). These
findings indicate that lola could affect a process common to
both mid- and late-oogenesis.
lola GLCs exhibit a disruption in the breakdown of nurse cell
nuclear membranes
The first signs of nurse cell death in late-oogenesis are
convolution and permeability of the nuclear envelope (Cooley
et al., 1992; Guild et al., 1997). This permeability can be
visualized with a nuclear β-galactosidase (β-gal) marker whichopmental PCD. TUNEL analysis (dark purple) and DAPI staining (blue) were
ient deprived females undergo checkpoint PCD and show TUNEL positive nurse
ntain TUNEL positive nuclei (arrows). (C) Mid-stage degenerating egg chambers
gg chambers. (D) Late-stage 12 and (E) early stage 13 heterozygous control egg
RC4 GLCs in a dumpless stage 14 egg chamber are not TUNEL positive.
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oogenesis (Cooley et al., 1992). Drosophila chickadee mutants
are known to exhibit a dumpless phenotype because actin
bundles fail to form and the nurse cells fail to transfer their
cytoplasm through the ring canals into the oocyte (Cooley et al.,
1992). Although this dumpless phenotype might suggest a
disruption in PCD, the nurse cells do in fact undergo normal
nuclear breakdown, as visualized with a nuclear β-gal marker
(Cooley et al., 1992).
To determine if the nurse cell nuclear envelope breaks down
normally in dumpless egg chambers containing lola GLCs, the
BB127 enhancer trap expressing nuclear β-gal in nurse cells
was used (Schüpbach and Wieschaus, 1991). Proper breakdown
of the nurse cell nuclear membranes would indicate a
cytoskeleton disruption as seen in chickadee mutants, whereas
failure to undergo nuclear breakdown would indicate a
disruption in the process of PCD. In control yw egg chambers,
nurse cell nuclear membranes are intact through stage 10 (Fig.
6A). At stage 10B, the nuclear membranes break down, as
indicated by the X-gal staining seen in the nurse cell cytoplasm
(Fig. 6B). By stage 12, the nurse cells have transferred their
cytoplasm to the oocyte, as indicated by the X-gal staining seen
now in the oocyte (Fig. 6C). Finally at stage 14, all the nurse cell
nuclei have undergone PCD, and the oocyte contains all of their
cytoplasmic contents (Fig. 6D). In dumpless egg chambers
containing lola629 GLCs, retention of X-gal staining inside
nurse cell nuclei indicates that the nuclear membranes of the
nurse cells fail to break down (Fig. 6E), suggesting that the
dumpless phenotype is indeed due to a disruption in the process
of PCD.
Egg chambers containing lola GLCs show abnormal
actin-cytoskeleton structure
During Drosophila oogenesis, cytoskeletal changes occur to
facilitate rapid cytoplasm transfer from the nurse cells into the
oocyte before the nurse cells complete developmental PCD. In
healthy early and mid-stage egg chambers, subcortical actin
surrounds each cell (Cooley et al., 1992; Nezis et al., 2006). In
addition, actin filaments make up intercellular cytoplasmicFig. 6. Nurse cell nuclear membranes do not break down in lola629 GLCs. (A–D) y w
encoding nuclear β-galactosidase and are X-gal stained (blue). (A) A stage 10 yw eg
cell nuclear membranes break down and X-gal staining leaks into the cytoplasm. (
staining is seen in the oocyte. (D) By stage 14, no nurse cells remain and all the X-g
GLCs retains X-gal staining in the nurse cell nuclei.bridges called ring canals that connect the nurse cells and
oocyte. Actin bundles form in the cytoplasm of the nurse cells
beginning at stage 10B and extend from the plasma membrane
to the nuclear membrane. These actin bundles are thought to
hold the nurse cell nuclei in place while the cytoplasm is
transported through the ring canals (Cooley et al., 1992).
Furthermore, these actin bundles are not normally seen during
the mid-stage checkpoint PCD which does not involve any
cytoplasmic transport (Nezis et al., 2000; Peterson et al., 2003).
To determine if the proper cytoskeletal changes occur in lola
mutants during PCD, we used rhodamine–phalloidin staining to
visualize actin. During the early stages of oogenesis, lola629
GLCs exhibit normal subcortical and ring canal actin (data not
shown). Dying mid-stage egg chambers, stage 10B egg
chambers, and dumpless egg chambers containing lola629
GLCs were also examined. Starvation-induced PCD during
mid-stages normally results in the formation of small clumps of
actin (Fig. 7B, arrows) when nurse cell nuclei are condensed
(Fig. 7A). However, degenerating egg chambers containing
lola629 GLCs contain abnormal actin structures (Figs. 7D and F,
white arrows). In heterozygous control degenerating mid-stage
egg chambers, the nurse cells complete PCD before the
surrounding follicle cells begin degenerating, as seen in wild-
type (Figs. 7A and B, arrowheads). In contrast, most of the
dying mid-stage egg chambers from lola629 GLCs (83%,
n=127) had follicle cells which appeared to degenerate at the
same or a faster rate than the nurse cells (Fig. 7D, arrowheads,
compared with Fig. 7B, arrowhead). In addition, a portion of
these egg chambers showed drastic differences in the degree of
nurse cell nuclear condensation within one egg chamber, with
uncondensed nuclei containing intact cellular membranes (Figs.
7E and F, yellow arrows). These results are consistent with
mutations in lola causing a delay in the checkpoint PCD
pathway as well as abnormal actin structure, and insufficient
nuclear condensation. In lola GLC egg chambers, only the
nurse cells and oocyte are homozygous for the mutation. The
follicle cells, which are heterozygous, appear to die normally
despite the lag in nurse cell death.
During developmental PCD, heterozygous control stage 10B
egg chambers exhibited normal actin bundle formation (Figs.hsflp control and (E) lola629 GLC egg chambers contain the BB127 enhancer trap
g chamber has intact nurse cell nuclear membranes. (B) By stage 10B, the nurse
C) A stage 12 yw egg chamber has undergone cytoplasmic transfer and X-gal
al staining is seen in the oocyte. (E) A dumpless egg chamber containing lola629
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lola629 GLCs showed disorganized actin bundles which were
frequently much thicker than normal and not found uniformlythroughout the egg chamber (Figs. 7I and J). Similar
disorganization of the actin cytoskeleton was seen in wild-
type egg chambers cultured in the presence of the caspase-3
inhibitor Z-DEVD-FMK, or treated with the cell death inducers
etoposide or staurosporine (Nezis et al., 2006). Dumpless egg
chambers continued to show disorganized actin structure (Figs.
7K–P) including small actin clumps usually seen only during
mid-stage checkpoint PCD (Fig. 7N, arrows). These results
indicate that cytoskeletal changes normally occurring during
developmental PCD to facilitate cytoplasmic transfer are
disrupted in lola629 GLCs. Furthermore, the appearance of
small actin clumps in dumpless egg chambers suggests the
undying nurse cells may initiate the checkpoint PCD pathway as
an alternative mechanism to die.
Mutations in lola cause variable levels of caspase activity
during both checkpoint and developmental programmed cell
death that are independent of chromatin condensation
To determine if lola alleles showed alterations in caspase
activation in mid- or late-oogenesis, egg chambers were labeled
with Cleaved Caspase-3 antibody. This antibody has been found
to detect robust caspase activity in egg chambers dying in mid-
oogenesis (reviewed in Baum et al., 2005). Condensed nuclei
and high levels of caspase activity were seen in heterozygous
degenerating mid-stage egg chambers, induced to undergo PCD
through nutrient deprivation of the adult females (Fig. 8A).
Upon starvation of females containing lola629 or lolaORC4
GLCs, mid-stage egg chambers also showed high levels of
caspase activation (Figs. 8B and C); however, it was not always
seen throughout the entire egg chamber and sometimes
localized to individual nurse cells (Fig. 8B). These results
indicate that mutations in lola can cause a disruption in caspase
activation and a delay in the checkpoint PCD pathway which is
more severe in some nurse cells than in others, even within the
same egg chamber.
Caspase activity in late-oogenesis was found to be variable in
lola629 and lolaORC4 GLCs. We did not detect any significant
staining in control nurse cells undergoing developmental PCD
in late-oogenesis with this antibody (Fig. 8D). Similarly, someFig. 7. Abnormal actin structure is seen in degenerating lola629 GLC egg
chambers. Panels depict DAPI staining (blue) on the left and rhodamine–
phalloidin staining (red) on the right of the same egg chambers. All images were
taken at the same magnification and rhodamine–phalloidin pictures were taken
at the same exposure. (A–B) A heterozygous mid-stage egg chamber
undergoing checkpoint PCD, induced through nutrient deprivation, contains
condensed nurse cell nuclei, small actin clumps (B, arrows) and follicle cells
with cellular membranes still intact (arrowheads). (C–F) lola629 GLC egg
chambers undergoing checkpoint PCD, without starvation, contain abnormal
actin structures (D and F, white arrows), degenerating follicle cells (D,
arrowheads), and uncondensed nurse cell nuclei with intact cellular membranes
(E and F, yellow arrows). (G–H) A stage 10B heterozygous egg chamber shows
formation of organized actin bundles in all nurse cells. (I–J) A stage 10B egg
chamber containing lola629 GLCs exhibits actin bundle formation that is
disorganized and not uniform throughout the nurse cells. (K–P) Dumpless egg
chambers containing lola629 GLCs continue to show disorganized actin struc-
ture. Some contain small actin clumps like those seen during mid-stage PCD
(N, arrows).
Fig. 8. Variable levels of caspase activity are seen during checkpoint and developmental PCD in lola629 and lolaORC4 GLCs. Cleaved Caspase-3 antibody staining
(green) depicts caspase activity and propidium iodide staining (red) shows nuclei. All images were taken at the same exposure and magnification. (A) A heterozygous
mid-stage egg chamber undergoing checkpoint PCD, induced by nutrient deprivation, shows condensed nurse cell nuclei and high levels of caspase activity throughout
the egg chamber. (B) Mid-stage egg chambers containing lolaORC4 or (C) lola629GLCs, undergoing checkpoint PCD, also show high levels of caspase activity, but it is
not uniformly found throughout the entire egg chamber. Nurse cells are not always condensed (B and C, arrows) and a lack of caspase activity is seen both with (B,
arrowheads) and without (B and C, arrows) nuclear condensation. (D) A heterozygous stage 12 egg chamber undergoing developmental PCD does not show significant
levels of caspase activity with this antibody. (E–G) Dumpless egg chambers containing lolaORC4 GLCs show either high levels of caspase activity (E), none (F), or
very low levels (G). Lack of proper nuclear condensation can also be seen in some of these dumpless egg chambers (G).
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caspase activity (Figs. 8F and G). However, others showed
caspase activity at much higher levels than those seen during
normal developmental PCD (Fig. 8E compared to D). These
high levels of caspase activity may indicate the initiation of the
checkpoint PCD pathway.
As noted before, in many lola GLC egg chambers under-
going PCD, normal condensation of individual nurse cell nuclei
does not always occur (Figs. 8B and C, arrows, and G). Upon
further investigation, we observed that both nurse cells
displaying condensation (Figs. 8B, arrowheads, and F) and
those without condensation (Figs. 8B and C, arrows, and G)
may lack caspase activity, suggesting that chromatin condensa-
tion can occur independently of caspase activation. Consistent
with our findings, it was recently determined that incubation of
developing wild-type egg chambers with the caspase-3 inhibitor
Z-DEVD-FMK does not affect chromatin condensation
although it does prevent DNA fragmentation and significantly
disrupts development of the egg chambers (Nezis et al., 2006).
Chromatin structure defects in lola GLCs increase with age of
the female
To determine how mutations in lola were specifically
affecting oogenesis and chromatin condensation, a time-courseexperiment was performed to monitor the progression of lola629
GLC phenotypes. Flies were conditioned for 1 to 12 days before
dissection. Fig. 9 shows representative pictures of ovaries from
flies of different ages containing lola629 GLCs. In one day old
flies, GLCs appeared normal (Fig. 9A). It is important to note
that the lack of stage 14 egg chambers was expected due to the
age of the flies. However, at 2 to 3 days (Figs. 9B–D), unusual
nuclei with abnormal sizes and shapes were apparent in GLCs.
By 4 days, masses of DNA were visible between GLC egg
chambers (Fig. 9E, arrow). In 7 to 8 day old flies, the ovaries
looked relatively messy and contained large masses of DNA
(Fig. 9F, arrow). Upon closer examination of these masses, they
appear to be the remnants of dying mid-stage egg chambers
which have failed to undergo proper nurse cell chromatin
condensation and engulfment. The follicle cells and cytoplasm
are gone and all that is left is the nurse cell nuclei. When caspase
activity was examined in these masses, it was clear that as the
follicle cells die and the nurse cell cytoplasm disintegrates, the
caspase activity leaves with it (Figs. 9G and H, arrows). It was
also observed that these large masses contain very few TUNEL
positive nuclei (data not shown), suggesting that proper and
complete chromatin condensation is required for DNA
fragmentation and is an essential part of PCD. These
chromatin-related phenotypes are all seen in addition to the
dumpless and persisting nurse cell nuclei phenotypes; however,
Fig. 9. lola629 GLCs exhibit chromatin defects that increase with age of the female. Egg chambers in panels A–G were stained with DAPI and (H) was stained with
Cleaved Caspase-3 antibody. (A) lola629 GLC tissue from a one day old female appears normal. (B–D) By 2–3 days, abnormally shaped nuclei, along with nuclear
condensation defects can be seen. (E) At four days, masses of nuclear material accumulate between egg chambers (arrow) and (F) by 7–8 days, these masses become
larger (arrow). (G–H) A group of egg chambers stained with DAPI (G) and Cleaved Caspase-3 antibody (H) show loss of caspase activity after the follicle cells die and
the nurse cell cytoplasm disperses (arrows). Remaining nuclear material in panel G may contribute to the masses in panels E–F. (A), (C), and (E–F) were taken at the
same magnification. (B), (D), and (G–H) were taken at higher magnification.
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dependent.
lola GLCs exhibit abnormal nuclear lamina morphology
A previous study showed that at least one Lola isoform
interacts with chromosomal kinase JIL-1, implicating lola as
being involved in chromatin structure regulation (Zhang et
al., 2003b). Examination of JIL-1 mutants has revealed
various defects in the ovaries including altered numbers of
nurse cells, excessive degeneration, and defects in DNA
amplification (Zhang et al., 2003a) as well as abnormal
nuclear lamina morphology (Bao et al., 2005). JIL-1 is
known to specifically regulate phosphorylation of serine 10
on histone H3 (Wang et al., 2001). Interestingly, we observed
transient, stage-specific labeling using an antibody recogniz-
ing this phosphorylation event, which coincided with the
onset of developmental PCD in the nurse cells (data not
shown). However, because the pattern of phosphorylation of
serine 10 on histone H3 in nurse cells occurs specifically and
transiently in later stage egg chambers, and because the
majority of lola GLCs are abnormal by that stage, we were
unable to compare levels of phospho-histone H3 (ser10)between lola GLCs and wild-type tissue. The involvement of
lola in oogenesis stemming from a role it plays in chromatin
structure regulation through interaction with JIL-1 seemed to
be a strong possibility.
JIL-1 has also been found to interact with Lamin Dm0, and
two distinct phenotypes observed in JIL-1 mutant ovaries were
the mislocalization of nuclear lamins and an abnormal
protrusion of the lamina through the ring canals near the oocyte
(Bao et al., 2005). Furthermore, the abnormal nuclear lamina
morphology in JIL-1 mutants was only observed in the nurse
cells and not in any embryonic or larval tissues examined (Bao
et al., 2005), suggesting that this interaction between JIL-1 and
Lamin Dm0 is of particular importance in the ovary. To
determine if the phenotypes observed in lola GLCs stem from
an interaction between Lola and JIL-1, we performed lamin
Dm0 antibody staining on both lola
629 and lolaORC4 GLCs.
Similar to JIL-1 mutant ovaries, we observed protrusions of
nuclear lamina through ring canals in lola GLCs when egg
chambers were double-labeled with lamin antibody (green) and
phalloidin (red) (Fig. 10B). This phenotype was observed in
18% of mid-stage egg chambers that otherwise appeared normal
(n=196), and these protrusions were never observed in
heterozygous control egg chambers (Fig. 10A).
Fig. 10. lola629 and lolaORC4 GLCs exhibit abnormal nuclear lamina morphology. Egg chambers in panels A–B were double-labeled with lamin Dm0 ADL84.12
antibody (green) and rhodamine–phalloidin (red). (A) Heterozygous control egg chambers exhibit normal nuclear lamina morphology. (B) A lolaORC4 GLC egg
chamber exhibits a protrusion of the nurse cell nuclear lamina through the ring canal (arrow, higher magnification inset). Egg chambers in panels C–H were stained
with lamin Dm0 ADL101 antibody (green, C, E, and G) and DAPI to visualize DNA (blue, D, F, and H). (C) Nuclear lamin Dm0 surrounds the nuclei in heterozygous
control egg chambers (higher magnification inset of nucleus indicated by arrow). (E and G) lola629 and lolaORC4 GLCs exhibit mislocalization of lamin Dm0 to the
cytoplasm (higher magnification insets of nuclei indicated by arrows). (F and H) No abnormal chromatin morphology is seen in the egg chambers with mislocalized
lamin Dm0 (compare with neighboring egg chambers and heterozygous controls in panel D).
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nuclear lamins in lola GLCs (Figs. 10E and G, arrows) when
compared to heterozygous control egg chambers (Fig. 10C).
This was seen in 22% of mid-stage egg chambers that otherwise
appeared normal (n=156). Interestingly, the abnormal chroma-
tin morphology frequently observed in lola GLCs was not
present in the GLC egg chambers exhibiting this mislocalization
of nuclear lamins (visualized by DAPI, Figs. 10F and H).
Additionally, this phenotype was typically seen in early stages
of oogenesis, suggesting that abnormal Lamin Dm0 distribution
may precede chromatin condensation defects in lola GLCs.
Furthermore, the observation of nuclear lamina morphology
defects in lola GLCs similar to those seen in JIL-1 mutant
ovaries suggests that Lola and JIL-1 may interact in the ovary.Discussion
The results of this study indicate that the axon guidance gene
lola is involved in PCD during both mid-oogenesis and late-
oogenesis. These two forms of PCD have distinct characteristics
(reviewed in McCall, 2004). The mid-oogenesis checkpoint
PCD is inducible through starvation, and the entire egg chamber
dies, including the nurse cells, oocyte, and follicle cells. On the
other hand, during late-oogenesis, only the nurse cells undergo
PCD as a natural part of the development of the egg chamber. In
addition, these two forms of cell death have been shown to
require different sets of genes. Despite these major differences,
each form of PCD involves chromatin condensation, DNA
fragmentation, and eventual engulfment of the nurse cell
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McCall, 2004).
It appears that lola is required for the chromatin condensation
that occurs during the checkpoint PCD in mid-oogenesis.
Without lola, egg chambers that have initiated the mid-stage
checkpoint PCD do not undergo proper nuclear condensation,
exhibiting either de-condensation, a complete lack of condensa-
tion, or an arrest at the condensed stage with no progression
towards fragmentation or engulfment of the dying nurse cells.
Although the presence of caspase activity and some chromatin
condensation indicates the checkpoint PCD pathway has been
initiated, it is incomplete. As a result, we see the degeneration of
the surrounding follicle cells prior to the disappearance of the
nurse cells and the accumulation of chromatin masses.
In late-oogenesis, normal development leads to PCD of the
nurse cells. However, in lola mutants, this pathway is not
triggered normally. Actin bundles form improperly, cytoplasmic
dumping fails to occur, and nurse cell nuclear membranes do
not break down. Nuclei usually do not condense normally,
similar to the condensation defects seen in mid-stage PCD, and
consequently, the nurse cells do not die. Consistent with a block
to this pathway, we see almost a complete absence of TUNEL-
positive nuclei in these dumpless egg chambers. However, some
dumpless egg chambers show high levels of caspase activation
comparable to mid-stage degenerating egg chambers. We
hypothesize that because caspases are activated to the same
levels as during mid-stage checkpoint PCD, the dumpless egg
chambers which show high levels of caspase activity may be
undergoing this checkpoint PCD rather than the true develop-
mental PCD. But without lola, there is a block or delay in the
pathway once it is initiated, and although nurse cells sometimes
appear to undergo chromatin condensation, the vast majority do
not display any subsequent DNA fragmentation. This is further
supported by the observance of small actin clump formation in
some dumpless egg chambers which resembles mid-stage dying
egg chambers.
Examination of the GLC phenotypes of several different
alleles of lola revealed that mutations in the 5′ variable region,
the constant region, and the 3′ variable region, specifically exon
22, can each cause severe defects in PCD during oogenesis. The
severe ovarian phenotypes of both lola629 and lolaORC4 suggest
that Lola isoform K plays a very important role during
oogenesis and a relatively minor role during the development
of the Drosophila nervous system. Both lola629 and lolaORC4
contain early stop codons located at residues 635 and 771
respectively, and both are located significantly before the zinc
finger domains in isoform K (this study; Goeke et al., 2003;
Horiuchi et al., 2003). The lolaORE50 allele contains a missense
mutation at residue 745 (Goeke et al., 2003) and a four bp
deletion causing a frameshift beginning at residue 777 (Goeke
et al., 2003; Horiuchi et al., 2003), eventually ending in an early
stop at residue 870. We were unable to generate GLCs of
lolaORE50; however, it is likely that this allele would also show a
major disruption during oogenesis.
In this study, intragenic complementation became a useful
mapping strategy. In and of itself, the pattern of complementa-
tion displayed by lola and the evolution of its use of trans-splicing is decidedly complex and worthy of much more
investigation. Modifier of mdg4 or mod(mdg4) is the only other
Drosophila gene besides lola currently known to exhibit the
phenomenon of interallelic complementation through trans-
splicing (Dorn et al., 2001; Mongelard et al., 2002). Through
this trans-splicing mechanism, mod(mdg4) has the ability, like
lola, to produce many different gene products. In addition,
mod(mdg4) has been shown to be involved in many different
cellular processes including nerve pathfinding, position effect
variegation, chromatin boundary establishment, and meiotic
chromosome pairing (Dorn and Krauss, 2003). It is also
interesting to note that Doom, a specific isoform of mod(mdg4),
was identified in a screen for cellular factors involved in PCD
(Harvey et al., 1997). Lola isoforms carry out a similarly wide
variety of cellular functions. lola is thought to encode
transcription factors implicated as playing important roles in
both the central and peripheral nervous systems (Giniger et al.,
1994; Madden et al., 1999; Crowner et al., 2002), chromatin
structure (Zhang et al., 2003b), and oogenesis (this study; E.
Giniger, personal communication). We have determined a
requirement for lola in the germline which does not seem to be
directly related to its requirements during embryonic develop-
ment of the nervous system. These findings highlight how
similar lola is to mod(mdg4) in carrying out a variety of
functions.
Both lola and mod(mdg4) contain an N-terminal BTB
domain (Dorn et al., 1993; Giniger et al., 1994). This domain is
found in the constant region of lola and is contained in all
isoforms (Goeke et al., 2003). Work in both C. elegans and S.
pombe revealed that BTB domain containing proteins can
interact with the ubiquitin ligase Cullin-3 (CUL-3) to target
protein substrates for degradation (Furukawa et al., 2003; Geyer
et al., 2003; Pintard et al., 2003; Xu et al., 2003). By directly
binding to CUL-3 through their BTB domains, these proteins
are thought to serve as adaptor molecules that recruit specific
substrates to CUL-3. With substrate specificity being mediated
by other domains found in these adaptors, a wide variety of
substrates can be sequestered by this one ubiquitin ligase. If
Lola interacts with dCul-3, this might explain how Lola
isoforms can carry out such a diverse group of cellular
functions. In addition to the BTB domain contained in every
isoform, 17 Lola isoforms contain unique zinc finger domains
(Goeke et al., 2003). One can hypothesize that each Lola
isoform may be recruiting a different set of substrates to dCul-3
through these unique exons and thus targeting them for
degradation. Recently guftagu (gft) was identified as the gene
encoding Drosophila Cullin-3 (dCul-3) (Mistry et al., 2004). It
was determined that high levels of dCul-3 are present in 0–1 h
old embryos suggesting a maternal contribution. Interestingly,
flies containing GLCs of gft failed to lay most eggs and the ones
that were laid appeared small and had dorsal appendage defects
(Mistry et al., 2004). Observation of gft GLCs revealed a severe
dumpless phenotype; however, none of the chromatin defects
seen in lola GLCs was present (data not shown). This suggests
that Lola is not interacting with dCul-3 in the ovary.
We observed abnormal nuclear lamina morphology in
isoform K-specific lola GLCs. The abnormal nuclear lamina
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seemed to precede the other abnormalities described. Previous
co-immunoprecipitation experiments have shown that at least
one Lola isoform (known as lola-PE and lola-PD, FlyBase) can
form a complex with chromosomal kinase JIL-1 (Zhang et al.,
2003b). A genetic interaction between lola and JIL-1 has also
been demonstrated using lola00642, an allele which is thought to
knock out several isoforms. lola00642 acted as a dominant
suppressor of JIL-1EP(3)3657 recessive semi-lethality, suggesting
an antagonistic interaction (Zhang et al., 2003b). Further studies
have shown that JIL-1 interacts with Lamin Dm0 in nurse cells
(Bao et al., 2005). It has been suggested that the interaction
between Lola and JIL-1 may be highly complex and dependent
on the specific isoform of Lola and the developmental context
(Zhang et al., 2003b). The same defects in the nuclear lamina
that we saw in lola GLCs have been described in JIL-1 mutant
ovaries, albeit with somewhat different penetrance. Specifically,
protrusions of the nuclear lamina through the ring canal were
observed in 42.8% of JIL-1 egg chambers, while mislocalized
lamins were observed in 5.2% of JIL-1 egg chambers (Bao et
al., 2005). However, overall JIL-1 mutant ovaries displayed
nuclear lamin defects in 48% of egg chambers while lola GLCs
displayed nuclear lamin defects in 40% of egg chambers,
indicating that a positive interaction between Lola isoform K
and JIL-1 may exist in the ovary. From this study, we cannot
conclude that this is a direct interaction, but the involvement of
lola in chromatin structure regulation during oogenesis
stemming from an interaction with JIL-1 and consequently
Lamin Dm0 remains a possibility.
Our studies suggest that lola isoform K is acting in a
pathway leading to the regulation of chromatin condensation
and completion of PCD during oogenesis. Analysis of other
isoform-specific lola mutants will help to determine which
isoforms are needed for proper PCD during oogenesis and
which are not. In addition, studies aimed at identifying targets of
the different isoforms will help determine the molecular
pathways in which Lola is acting during oogenesis.
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